2014
DOI: 10.1007/s12032-014-0017-5
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma

Abstract: Transient receptor potential vanilloid 2 (TRPV2) was proved to play a crucial role in the tumor progression of various cancers. The association between the expression of TRPV2 and clinical outcome in cancer patients has not been studied yet. We aim to elucidate the role of TRPV2 in predicting prognosis of patients with esophageal squamous cell carcinoma (ESCC). Fresh frozen samples were collected immediately from 170 patients with ESCC after surgical resection from 2003 to 2008, including 45 pairs of tumor tis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(31 citation statements)
references
References 24 publications
1
29
0
1
Order By: Relevance
“…Expression of TRP channels has been correlated with the aggressivity of multiple cancer forms, both in model systems [ 47 ] and in clinical investigations [ 48 , 49 ]. Similarly LL-37 has been linked to development and progression of various cancer forms.…”
Section: Discussionmentioning
confidence: 99%
“…Expression of TRP channels has been correlated with the aggressivity of multiple cancer forms, both in model systems [ 47 ] and in clinical investigations [ 48 , 49 ]. Similarly LL-37 has been linked to development and progression of various cancer forms.…”
Section: Discussionmentioning
confidence: 99%
“…Deregulation of TRPV2 expression has been reported in several solid cancers including prostate cancers, bladder cancers, hepatocellular carcinoma and esophageal squamous cell carcinoma (Santoni et al 2011). TRPV2 was always found expressed at higher levels in samples from patients with metastatic disease than in solid primary tumors and associated with poor prognosis, consistent with a role in metastasis formation (Caprodossi et al 2008;Monet et al 2010;Zhou et al 2014). TRPV2 characterization during prostate cancer progression best illustrates the tumorigenic potential of TRPV2.…”
Section: Trpvsmentioning
confidence: 90%
“…We also assessed more than 200 ESCC patient samples, including fresh samples and para n slides, and found that TRPV2 was upregulated among > 87% of the fresh tumor samples and > 84% of the tumor slides compared with the non-tumor control samples. Previously, Zhou et al reported that overexpression of TRPV2 is associated with poor prognosis in patients with ESCC [55] and Atsushi proposed that TRPV2 is involved in the maintenance of CSCs (cancer stem cells) of ESCC [56]. Recently, Michihiro et al described that overexpression of TRPV2 in two ESCC cell lines (TE15 and KYSE170) and TRPV2 strong expression is associated with a worse prognosis in ESCC patients [57].…”
Section: Discussionmentioning
confidence: 99%